A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care

被引:46
|
作者
Blak, B. T. [1 ]
Smith, H. T. [2 ]
Hards, M. [1 ]
Maguire, A. [3 ]
Gimeno, V. [4 ]
机构
[1] Cegedim Strateg Data Med Res Ltd, London NW1 0QG, England
[2] Lilly UK, Erl Wood Manor, Windlesham, Surrey, England
[3] United BioSource Corp, Ctr Epidemiol & Database Analyt, London, England
[4] Lundbeck, Barcelona, Spain
关键词
Insulin treatment; Type; 2; diabetes; Primary Care; TO-TARGET TRIAL; NPH INSULIN; THERAPY; MELLITUS; PEOPLE; AGENTS; VALIDATION; MANAGEMENT; SECRETION; ALGORITHM;
D O I
10.1111/j.1464-5491.2012.03694.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabet. Med. 29, e191e198 (2012) Abstract Aims This study characterized UK primary care patients with Type 2 diabetes who initiated insulin treatment, and described the initial insulin regimens used, overall metabolic changes and health-care resource usage. Methods A retrospective cohort study was performed using quality-checked patient data from The Health Improvement Network database. Eligible patients who initiated insulin for the first time between 2004 and 2006 were grouped into four cohorts according to the type of insulin regimen initiated. Data on patient characteristics, metabolic and clinical outcomes and health-care resource use were collected at baseline and during 6 months of follow-up. Results In total, 4045 eligible adults [2269 male, 1776 female; mean age 62.6 +/- 13.3 years; mean baseline HbA1c 82 +/- 22 mmol/mol (9.6% +/- 2.0%)] initiated insulin. Approximately half (52.4%) initiated insulin as basal insulin only, 41.6% as premixed only, 4.0% as basal-bolus and 2.1% as prandial insulin only. Among patients with = 180 days follow-up (n = 3815), the initial insulin regimen was not changed during follow-up in 75.1% of patients, while 13.7% discontinued, 7.0% switched and 4.7% intensified insulin therapy. The mean change in HbA1c was -14 mmol/mol (-1.3%, n = 2881), with 17.3% of patients achieving an HbA1c of < 53 mmol/mol (7%, n = 3024). The mean weight change was +0.9 kg (n = 2345). Conclusions Basal and premixed insulin were the most common types of insulin initiated and in most patients no changes were made to the initial regimen over 6 months. However, few patients achieved glycemic control targets.
引用
收藏
页码:E191 / E198
页数:8
相关论文
共 50 条
  • [41] The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
    Poole, Chris D.
    Tetlow, Tony
    McEwan, Phil
    Holmes, Paul
    Currie, Craig J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S41 - S48
  • [42] Direct medical costs of severe hypoglycaemic events amongst type 2 diabetes patients in the UK: a retrospective database study
    Tunceli, K.
    Holbrook, T.
    Williams, J.
    Shankar, R.
    Chen, J.
    Radican, L.
    Piercy, J.
    DIABETOLOGIA, 2015, 58 : S158 - S158
  • [43] Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis
    He, Xiaoning
    Chen, Liming
    Wang, Ke
    Wu, Haiya
    Wu, Jing
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 237 - 245
  • [44] A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE WITH INSULIN IN PATIENTS WITH TYPE 2 DIABETES ADDING MEALTIME INSULIN TO A BASAL REGIMEN
    Kalsekar, A.
    Bonafede, M. M.
    Pawaskar, M. D.
    McGuffie, K.
    Torres, A.
    Kelly, K. R.
    Curkendall, S.
    VALUE IN HEALTH, 2009, 12 (07) : A413 - A413
  • [45] Insulin initiation experiences in people with Type 2 diabetes: data from the UK
    Hassan, S. W.
    Hadjiyianni, I.
    Ivanova, J.
    Cao, D.
    Gulati, K.
    Tahbaz, A.
    Perez-Nieves, M.
    DIABETIC MEDICINE, 2017, 34 : 189 - 189
  • [46] Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study
    Ruzafa, J. Cid
    Paczkowski, R.
    Boye, K. S.
    Di Tanna, G. L.
    Sheetz, M. J.
    Donaldson, R.
    Breyer, M. D.
    Neasham, D.
    Voelker, J. R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (08) : 871 - 882
  • [47] Perceptions of primary and secondary care providers on initiation and intensification of Type 2 diabetes injectable therapies in primary care: a quantitative survey in the UK
    Sterzi, D.
    Auziere, S.
    Glah, D.
    Jensen, M. Markert
    DIABETIC MEDICINE, 2016, 33 : 194 - 194
  • [48] Insulin initiation in Type 2 diabetes
    Page, S
    DIABETIC MEDICINE, 2005, 22 : 2 - 5
  • [49] The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
    Currie, Craig J.
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    McEwan, Phil
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S33 - S39
  • [50] The management of people with Type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study
    Calvert, M. J.
    McManus, R. J.
    Freemantle, N.
    DIABETIC MEDICINE, 2007, 24 : 43 - 43